Latest news

Cuba registers new skin cancer medicine

Cuba has registered a new skin cancer medicine called “Heberferon” developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB – as “unique” in the world. The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such […]

Heberprot-P registered in 23 countries

Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber¬prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results Developed by a team of experts led by Dr. Jorge Berlanga Acosta from the Center for Genetic Engineering and Biotechnology (CIGB), Heber­prot-P is an injectable medication used to treat advanced foot ulcers in diabetic patients by accelerating the healing process, thus reducing the risk of amputation in over 78% of cases. The only one of its kind in the world, the product received the Gold Medal awarded […]

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

By reopening embassies, removing Cuba from the “terror list” and making it a bit easier for Americans to travel there, President Barack Obama’s White House has taken initial steps to put an end to a policy that has adversely affected the health of the American people for over half a century. The Senate Appropriation Committee’s action last week to even further ease restrictions on travel to Cuba by U.S. citizens and relax some provisions of the economic embargo, is welcome for a variety of reasons, but perhaps most urgently for the health of citizens in both countries. Forty years ago, […]

see all our news

Next events